# reload+after+2024-01-21 17:43:26.828737
address1§505 Lomas Santa Fe
address2§Suite 160
city§Solana Beach
state§CA
zip§92075
country§United States
phone§858 925 7049
website§https://www.artelobio.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for treating breast and prostate cancer, neuropathic and nociceptive pain, and anxiety disorders, including PTSD. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.
fullTimeEmployees§5
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Gregory D. Gorgas M.B.A.', 'age': 60, 'title': 'President, CEO, CFO, Treasurer, Secretary & Director', 'yearBorn': 1963, 'fiscalYear': 2022, 'totalPay': 654831, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Andrew  Yates Ph.D.', 'title': 'Senior VP & Chief Scientific Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Steven D. Reich', 'age': 77, 'title': 'Chief Medical Officer', 'yearBorn': 1946, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jason H. Baybutt', 'age': 51, 'title': 'Senior Vice President of Finance', 'yearBorn': 1972, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.126
currency§USD
dateShortInterest§1702598400
forwardEps§-1.04
exchange§NCM
quoteType§EQUITY
shortName§Artelo Biosciences, Inc.
longName§Artelo Biosciences, Inc.
firstTradeDateEpochUtc§1561123800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§f3ba8d6d-cd41-3b55-b7aa-d9f9e6994cce
gmtOffSetMilliseconds§-18000000
targetHighPrice§40.0
targetLowPrice§5.0
targetMeanPrice§16.67
targetMedianPrice§5.0
recommendationMean§1.7
recommendationKey§buy
numberOfAnalystOpinions§3
quickRatio§13.967
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
